Next Article in Journal
Antimicrobial Properties of Basil (Ocimum basilicum L.), Sage (Salvia officinalis L.), Lavender (Lavandula officinalis L.), Immortelle (Helichrysum italicum (Roth) G. Don), and Savory (Satureja montana L.) and Their Application in Hard Cheese Production
Previous Article in Journal
Reusable Medical Device Pre-Cleaning in Care Units: What Are the Indicators to Prevent Biofilm Formation and Control Occupational Biological Risk?
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Prevalence of Contagious Mastitis Pathogens in Bulk Tank Milk from Dairy Farms in Lower Saxony, Germany

1
Faculty II, Microbiology, Hannover University of Applied Sciences and Arts, 30453 Hannover, Germany
2
Faculty of Health and Medical Sciences, Department of Veterinary and Animal Sciences, Section for Production, Nutrition and Health, University of Copenhagen, 1870 Frederiksberg, Denmark
*
Author to whom correspondence should be addressed.
Hygiene 2024, 4(2), 122-134; https://doi.org/10.3390/hygiene4020009
Submission received: 24 February 2024 / Revised: 21 March 2024 / Accepted: 22 March 2024 / Published: 26 March 2024
(This article belongs to the Section Veterinary, Livestock, and Biosafety)

Abstract

:
The aim of this study was to determine the prevalence of Streptococcus (Sc.) agalactiae, Prototheca spp., Staphylococcus (S.) aureus, and especially methicillin-resistant S. aureus as well as Myco-plasmopsis (M.) spp. and M. bovis in bulk tank milk (BTM) on dairy farms in Lower Saxony, Germany. BTM samples were collected in January 2023 from 208 selected dairy farms. The samples were quantitatively culturally analyzed for S. aureus and Prototheca spp. Presumptive S. aureus colonies were further confirmed by MALDI-TOF. Presumptive Prototheca spp. colonies were confirmed by light microscopy. Sc. agalactiae and Mycoplasmopsis spp. were detected by real-time polymerase chain reaction (rtPCR). Sc. agalactiae was detected in two herds (1% (Confidence Interval 95% (CI) 0.3–3.4)). S. aureus was confirmed by matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) in 38 herds (18.3% (CI 13.6–24.1)), assuming a threshold of >10 cfu/mL milk. A total of 154 isolates identified as S. aureus by MALDI-TOF were transferred to agar with added oxacillin for resistance testing, of which 19 isolates (12.3% (CI 8–18.5)) showed growth. The 19 isolates came from eight different farms (3.8% (2–7.4)). Prototheca spp. were identified in 13 herds (6.3% (CI 3.7–10.4)). Mycoplasmopsis spp. were detected by PCR in 18 herds (8.7% (CI 5.5–13.3)). Of these, M. bovis was present in three herds (1.4% (0.5–4.2)). The herd prevalence of Sc. agalactiae in BTM appears to be at low levels in the sampled area. The prevalence of Mycoplasmopsis spp. in the herds was higher than expected compared to previous studies. It is interesting to note that the percentage of M. bovis in the total Mycoplasmopsis spp. was only 16.7%.

1. Introduction

Mastitis is considered the most important production disease in dairy cows, resulting in high economic losses in the dairy industry [1,2]. Mastitis is a multifactorial disease, with the relevance and frequency of infectious factors constantly evolving [3,4]. The role of various “rare” mastitis pathogens is controversially discussed in the literature.
The analysis of bulk tank milk (BTM) is a simple, fast, and inexpensive alternative or adjunct to the analysis of quarter milk samples. The interpretation of the results is particularly useful for qualitative or semi-quantitative tests. The quantitative testing of BTM is useful for pathogens whose increased presence in bulk milk can lead to an increased risk of pathogen spread and increased risk of new infections on the farm. BTM testing can be used primarily for the early detection of infection risks from microorganisms that are transmitted during milking and which, due to their high rate of spread, pose a massive threat to udder health on dairy farms [5]. It can also be useful as an adjunct to herd sanitation, for example, in the case of Mycoplasmopsis (M.) spp. [6]. BTM is therefore a herd risk assessment test. Ideally, the microorganisms tested should be undetectable. However, in the case of Staphylococcus (S.) aureus, the risk of infected cows increases with increasing herd size and the associated increase in milkings per cluster. Thus, a limit of more than 10 cfu S. aureus/mL of bulk milk is considered to increase the risk of infection [7]. If Streptococcus (Sc.) agalactiae and/or Mycoplasmopsis spp. are detected, immediate action is required to achieve pathogen-free status [5]. In the case of Prototheca (P.) spp., an overview of their distribution on German cattle farms is of particular interest, as few data are available on this subject.
Although there are no longitudinal studies on the herd prevalence of Sc. agalactiae in Germany, the prevalence of intramammary infections caused by Sc. agalactiae has long been reported to decrease in recent years, especially since it was assumed that adequate therapy with penicillin would eradicate the pathogen [8,9,10]. In Germany, the treatment of Sc. agalactiae mastitis has been recommended for more than seventy years. In particular, the application of penicillin and the systematic drying-off of cows with penicillin on farms with Sc. agalactiae has been described since 1953. This resulted in a significant reduction in Sc. agalactiae in German dairy farms and a shift in mastitis pathogens towards S. aureus and later environmental pathogens, but a complete disappearance of Sc. agalactiae was not achieved [11]. In recent years, there have been increasing reports that the prevalence of Sc. agalactiae infections is increasing again [12,13,14]. Those studies are mainly from the Scandinavian countries. The study by Mweu et al. from Denmark, analyzing bacteriological culture data from all BTM samples collected annually as part of the Danish mandatory surveillance program for Sc. agalactiae, describes a steady increase in prevalence from 1.2% to 4.7% between 2000 and 2008. This suggests that the eradication of the pathogen has not been successful and that Sc. agalactiae may play a greater role in the pathogen spectrum of mastitis pathogens in the future. In a German study of pathogen distribution in microbiologically positive (quarter) milk samples from all laboratories using the German diagnostic standard, a proportion of 2% (0.1–4.3) Sc. agalactiae was observed [15]. In general, the presence of Sc. agalactiae indicates problems in herd management, as Sc. agalactiae is a pathogen that can be eliminated from individual animals with appropriate antibiotic therapy. The elimination of the pathogen is desirable for a long-term udder healthy herd, although this is difficult to achieve on very large farms [7]. Poor teat and udder hygiene, poor environmental hygiene, and a farm with a high number of cows have been described as risk factors [12,16,17]. The entry of the pathogen onto the farm can occur especially in the case of poor internal biosecurity or the purchase of new infected animals [8]. Infection with Sc. Agalactiae usually results in subclinical mastitis (SCM), with a sharp increase in cell count. However, it can also cause severe clinical mastitis (CM), with a complete cessation of milk production. Sc. agalactiae is an obligate pathogen of the mammary gland, and infection is generally known to be transmitted during milking, with recent studies also describing the possible environmental attachment of the pathogen and potential infection by this route [8,18,19].
Prototheca spp. and methicillin-resistant S. aureus (MRSA) are described as other “rare” mastitis pathogens that should be considered mainly because of the great difficulty in treating them, as no evidence-based therapies are described [20], and, in the case of MRSA, because of its potential zoonotic risk [21,22]. Recent studies have reported a rise in the number of cases of both MRSA [23,24] and Prototheca spp. [25].
Prototheca spp. are colorless algae that are well established in the environment. Therefore, both types of transmission—environmental and contagious—are possible. When a Prototheca spp. infection occurs in the herd, several animals are usually affected at the same time. Predisposing factors include poor hygiene, wet areas, and the heavy, uncontrolled use of antibiotics [26]. Mastitis caused by Prototheca spp. often occurs as a chronic process with very high somatic cell counts (SCC). However, acute CM has also been reported [27,28]. There is no known therapy with good efficacy against the pathogen [29,30,31]. As it is often a livestock problem, extensive remediation measures are required, resulting in high economic losses. The pathogen is still rarely associated with CM, but an increased incidence has been reported recently [32]. A recent Polish study described Prototheca spp. as the third most important pathogen after staphylococci and streptococci [25]. This raises the question of whether the pathogen should also be classified as rare on German dairy farms. A Canadian study of tank milk found a prevalence of 6% [33].
In general, S. aureus is one of the most common mastitis pathogens worldwide. In Lower Saxony, Germany, it represents only a small proportion of clinical cases of mastitis in studies. For example, in a recent study, the percentage of S. aureus in CM cases was 3.7% [34]. In 2019, the analysis of pathogen distribution in microbiologically positive (quarter) milk samples revealed a proportion of S. aureus of 11.4% in Germany and 5.3% in the sampled region [15]. S. aureus is a cow-associated pathogen with numerous pathogenicity factors that make it difficult to control [35]. Since it is almost impossible to eliminate S. aureus from the herd, the most important aspect is to improve working standards to prevent new infections.
MRSA shows resistance to ß-lactam antibiotics and further limits treatment options, resulting in increased culling rates [20,24]. The potential zoonotic risk is important from a societal perspective, as there are ongoing discussions about increased antibiotic use and antibiotic resistance in livestock. However, the risk of transmitting MRSA to humans through milk is considered very low if the milk is properly processed and controlled [36]. MRSA infections are associated with both CM and SCM [22]. MRSA transmission in dairy herds is primarily associated with poor milking hygiene practices [19]. Recent studies showed an increasing trend of MRSA in the dairy industry [24]. A study described an increase in prevalence from 4.1% in 2009 to 9.7% in 2014 [23]. A meta-analysis estimating the global prevalence of MRSA isolated from bovine mastitis cases described an average prevalence of 4–30%, with the lowest prevalence described in Europe at 1–18% [37]. In Germany, a comparison of three cross-sectional studies shows that the prevalence of MRSA increased slightly from 2010 to 2014 but decreased again slightly until 2019. Larger conventional farms are more frequently affected than smaller and organic farms [38].
The infections caused by Mycoplasmopsis spp., especially M. bovis, are characterized by a high infectious potential. The transmission of the pathogen occurs during the milking process. Herd size is estimated to be a significant risk factor [39,40]. It causes many other diseases in cows besides mastitis. Chronically infected animals are the reservoir for the pathogen and the main risk factor for introducing it to a farm is infected purchased animals. In general, Mycoplasopsis spp. is a normal colonizer of the upper respiratory, genitourinary, and digestive tracts of cows. Occurrence in the udder (milk) indicates problems. M. bovis infections result in subclinical, mild clinical, or severe mastitis [41]. Several quarters are usually affected. In milder forms, cows do not show any general signs of distress. In clinical cases, the affected quarters show atrophy and agalactia [40]. M. bovis is characterized by natural resistance to antibiotics that interfere with cell wall synthesis. The pathogen has been described as insensitive to therapeutic intervention. However, the disease is also often self-limiting and disappears some time after the outbreak, sometimes without targeted intervention. In most cases, however, a rapid culling of the cows is advisable to prevent new infections in other cows [40,42]. There are recommendations to cull all cows that test positive for mycoplasma, or to cull only cows with CM that test positive for Mycoplasmopsis spp., as it is believed that intramammary mycoplasma infections are self-limiting [6]. The herd prevalence in Germany, in the Weser-Ems region, was 1.46% in 2012 [43]. In other countries, prevalences of 1.5% (Belgium) and 3.4% (Canada) have been described [44,45]. An Israeli longitudinal study reported values of 0–0.68% between 2004 and 2007, 3.77% in 2008, and 0.77–2.77% between 2009 and 2014 [46].
The aim of this study is to obtain information on the current herd prevalence in the collection area of the Central Weser Milk Control Association (CWMCA), Germany, and to gain knowledge on the importance of the pathogens addressed to obtain an up-to-date, sample-based overview of the possible occurrence of the pathogens. To detect increasing trends at an early stage, it is important to closely monitor the “rare” but contagious, zoonotic, and difficult-to-treat pathogens. This enables rapid intervention when numbers increase, preventing serious economic and animal health problems. The benefits of testing BTM samples can be discussed in this context.

2. Materials and Methods

All applicable guidelines for the care and use of animals were followed. The study was approved by the Animal Welfare Committee of the university (University of Veterinary Medicine Hannover, Foundation, Hannover, Germany; file reference: TVO-2022-V-56). The date when ethical approval was obtained was 29 August 2022. An application for a license for animal testing was not required by the local government due to the study design. The study complied with the International Guiding Principles for Biomedical Research Involving Animals (1985).

2.1. Milk Samplings—BTM

For this study, BTM samples were acquired from the CWMCA in Germany. Only farms with a single milk collection volume of more than 4000 L were included in this study. This represents farms with a size of approx. 80 cows or more in lactation, if calculated with a two-day collection and an average production per cow per day of 25 L of milk. The total number of samples was 226 from 208 different farms. Each farm was sampled on Friday, 28 January and Saturday, 29 January 2023. The unpreserved milk samples were then sent refrigerated to the microbiology laboratory of the University of Applied Sciences and Arts (Hannover, Germany) for testing on 30 January 2023.
BTM samples were analyzed by real-time polymerase chain reaction (rtPCR) for Mycoplasmopsis spp., M. bovis, and Sc. agalactiae. The determination of S. aureus and Prototheca spp. was detected by culturing on selective media. The further differentiation of grown colonies was performed by MALDI TOF analysis. In addition, S. aureus isolates were tested for oxacillin resistance.

2.2. Data Sampling

To identify possible risk factors or consequences, further parameters were recorded. The following data were collected: the total number of cows on the farm, cows in lactation at the time of sampling, average milk production in kg per cow per day, milking technique (robot or conventional), cell count from January to May 2023 as a geometric mean, and average SCC at the time of sampling in the milk performance test. To ensure the anonymity of the data, it was only possible to generate data from the farms that were available to the CWMCA. Data were available for the following number of positive farms: for Sc. agalactiae in 1 of 2 farms, Prototheca spp. in 9 of 13 farms, S. aureus in 28 of 38 farms, oxacillin-resistant S. aureus in 5 of 8 farms, Mycoplasmopsis spp. in 13 of 18 farms, and M. bovis in 3 of 3 farms. The mean values obtained were compared with the available data from the annual reports of the CMWCA and the State Control Association of Lower Saxony (SCALS) [47].

2.3. DNA Extraction and PCR Analysis

For chromosomal DNA extraction from milk, the DNeasy Blood and Tissue Kit from Qiagen GmbH, Hilden, Germany, was used and PCR was performed according to previously published methods [48,49,50]. The primers used and the corresponding nucleotide sequences are shown in Table 1 and the primer conditions during PCR are shown in Table 2.

2.4. Determination of Presumptive S. aureus in BTM

For enumeration to estimate the number of S. aureus per mL of tank milk as an expression of the biosecurity of S. aureus on the farm, Baird Parker agar supplemented with egg yolk tellurite emulsion was used and evaluated accordingly [51,52]. Presumptive S. aureus colonies were examined by MALDI-TOF. Plates with more than one presumptive colony detected in 0.1 mL (≈ >10 cfu/mL) were considered positive. This method can be used to identify farms with an increased risk of spreading S. aureus. A value greater than 10 cfu/mL indicates that there are too many infected animals or animals with too much pathogen shedding on the farm [7,53].
All confirmed S. aureus isolates underwent an oxacillin resistance screening in accordance with CLSI 2013 VET01-A4. Therefore, the isolates were streaked on Mueller-Hinton agar with 4% NaCl (0.68 mol/L) and 6µg oxacillin/mL and examined for growth.

2.5. Determination of Prototheca spp. in BTM

Prototheca spp. were enumerated by inoculating 100 µL and a tenfold dilution of the tank milk sample on Yeast Extract Glucose Chloramphenicol (YGC) agar followed by incubation at 25 °C for 72 h. To distinguish grown Prototheca spp. colonies from yeast colonies, Gram staining and microscopy were performed [51].

3. Results

In 2023, 546 farms with an average herd size of 143.6 cows were represented in the CWMCA. The average milk on CWMCA farms in 2023 was 10,701 kg per cow per year. In the entire SCALS, the number of farms was 5810 with an average cow number of 122.8 and an average milk yield per cow per year of 10,034 kg in 2023. In the SCALS, the average SCC from October 2022 to September 2023 was 234 × 103 cells/mL. In January 2023, the average SCC was 229 × 103 cells/mL. In 2022, 21.9% of all farms in the SCALS had an automatic milking system. In the CWMCA, the proportion was 29%. The participating farms had more than approximately 80 cows in lactation. A total of 226 samples were analyzed from these 208 herds.
Table 3 shows the herd prevalences and associated 95% confidence intervals for the different pathogens.
Sc. agalactiae was detected by PCR in the BTM from two herds (1% (Confidence Interval 95% (CI) 0.3–3.4)).
The PCR for Mycoplasmopsis spp. was positive in 19 samples from 18 different herds (8.7% (CI 5.5–13.3)). Of these, M. bovis was present in three herds (1.4% (CI 0.5–4.2)). Therefore, M. bovis accounted for 16.7% of the total Mycoplasmopsis spp. detected in BTM.
Presumptive S. aureus colonies with a threshold of >10 cfu/mL milk were found in 181 of 226 (80.1% (CI 74.4–84.8)) samples cultured on Baird-Parker agar. Of these, S. aureus was confirmed by MALDI-TOF in the BTM of 38 herds (18.3% (CI 13.6–24.1)). The other presumptive colonies were mostly non-aureus staphylococci (NaS). A total of 154 isolates identified as S. aureus by MALDI-TOF were transferred to agar with added oxacillin for resistance testing, of which 19 isolates (12.3% (CI 8–18.5)) showed growth. The 19 isolates came from eight different farms and resulted in a herd prevalence of S. aureus with an oxacillin resistance of 3.8% (CI 2–7.4).
Prototheca spp. were detected on 13 farms (6.3% (CI 3.7–10.4)) by culture on YGC agar and a microscopic identification of BTM.
As shown in Table 4 and Figure 1, the farms that were positive for Prototheca spp. (386), Mycoplasmopsis spp. (225), and M. bovis (290) had on average more animals than the average farm in the SCALS and CWMCA (123/144). The difference for the Prototheca spp. positive farms was as much as 242 more cows than on the average farm in the CMWCA.
The average milk yield per animal per day was highest on Mycoplasmopsis spp. positive farms with 33.6 kg and lowest on Sc. agalactiae positive farms with 29.7 kg and oxacillin-resistant S. aureus positive farms with 30.9 kg. The corresponding comparison of average milk yields is shown in Figure 2.
In the SCALS, 21.9% of all farms had an automatic milking system in 2022. This value was lower for most farms that were positive for a pathogen in the bulk milk (Figure 3). In the case of oxacillin-resistant S. aureus and M. bovis, the cows on all farms that were positive for a pathogen in bulk milk were even milked conventionally. Only in the case of S. aureus (32.1%) and Sc. agalactiae (100%) was the proportion of farms with automatic milking systems higher than the average of all farms (Figure 3).
Regarding the SCC at the time of sampling, especially farms with a positive finding for bulk milk for Mycoplasmopsis spp. (290 × 103 cells/mL), Prototheca spp. (273 × 100 cells/mL) and S. aureus (259 × 103 cells/mL) had a higher SCC than the average of all farms belonging to the SCALS and CWMCA (234 × 103 cells/mL/245 × 103 cells/mL). A comparison of the average SCC is shown in Figure 4.

4. Discussion

The quality of bulk milk testing depends on several factors. However, the microbiological testing of BTM is a key benefit for general monitoring to assess the mastitis situation in sanitation programs, for initial or overview testing on farms that do not have up-to-date data, and for periodic testing to assess treatment success on larger farms. A qualitative or semi-quantitative test is therefore most useful for pathogens that should not be detectable on the farm, or at least not in the milk. Examples of such pathogens are Sc. agalactiae, Mycoplasmopsis spp., and Prototheca spp. [5,13]. In the case of S. aureus, a quantitative test of the BTM is useful as it gives an indication of the current level of hygiene measures, i.e., the current risk of spreading the pathogen. If more than 10 cfu/mL of S. aureus is detected in the BTM, the farm is considered to be at risk of having too many cows infected with S. aureus or cows with very high pathogen shedding [7]. It should be noted that there is a greater need for caution when interpreting quantitative results than qualitative or semi-quantitative studies. The contamination of bulk milk must be considered, especially by environmental pathogens and skin colonizers (e.g., NaS). [5,51]. It is important to note that not all cows are milked into the tank. BTM contains the milk of lactating cows whose milk is suitable for human consumption. Cows with CM are usually milked separately. Therefore, BTM testing can only be used as a tool to screen for specific pathogens, in order to identify unrecognized carriers or a generally high pathogen potential in the herd, or to detect newly emerging pathogens. In particular, control tests of BTM for contagious pathogens such as Sc. agalactiae, S. aureus, and Mycoplasma spp. are considered useful in long-term control and eradication strategies [51]. Several studies support this viewpoint and conclude that a regular testing of BTM is crucial [44,54,55]. In conclusion, a positive test result provides useful information for the farm, while a negative result does not necessarily mean that the pathogen is not present or does not pose a problem or risk to the herd.
The herd prevalence of Sc. agalactiae in BTM was 1%, which is well below the values found in Scandinavian studies [12,13,14]. Herd prevalence appears to be at a similar level with prevalence in positive quarter milk samples from a previous German study [15]. In a comparable study from Germany, where 51 herds were tested for Sc. agalactiae, only one herd tested positive in BTM and quarter milk samples [54]. A study from Switzerland reported a prevalence of Sc. agalactiae of 0.2%/0.5% at quarter/cow level and 2.1% at farm level [56], which is close to the level found in our study. In other European countries, higher prevalences of Sc. agalactiae were found in some cases (5.8% in Slovakia and 15.6% in Poland), but these studies examined quarter milk samples from cows with present mastitis [57,58].
However, it is important to note that the farm structure in the sampled area differed significantly from the farm structure found in large parts of Scandinavian farms. Since Sc. agalactiae is most problematic on farms with very large numbers of animals [12,16,17], and there were no farms with more than 1000 cows on the sampled farms, this must be considered. In addition, selective drying off and greater restrictions on the use of antibiotics were introduced early on in Scandinavian countries, so it may not have been possible to completely eradicate the pathogen from affected cows. Sc. agalactiae is more prevalent on farms with automatic milking systems. Also, in the present study, the only positive finding for which data were available was a farm with an automatic milking system. However, it should be kept in mind that this was an isolated case, so an incidental finding is possible. To identify possible reservoir farms for Sc. agalactiae, further work should focus on the investigation of larger farms with high cow numbers. A major risk factor for bringing Sc. agalactiae onto the farm is the purchase of infected animals. It is therefore advisable to regularly check the status of Sc. agalactiae via BTM, especially if there are large or regular changes in the herd, such as the purchase of new cows [7].
Testing for Mycoplasmopsis spp. in BTM showed a higher prevalence than previous studies [43,44,45], whereas the detected prevalence of M. bovis of 1.4% is consistent with the detected prevalence of 1.5% in Belgium [45], but higher than in a comparable study from France, where none of the 345 BTM samples were positive, giving a prevalence of <1% [59]. In a Portuguese study investigating BTM, a prevalence of 3% was described for Mycoplasmopsis spp. and 2.4% for M. bovis [60]. Thus, in this study, the proportion of M. bovis in the total of positive Mycoplasmopsis spp. samples is higher than in our study. Herd size has been described as a critical factor [39,40,60]. This can be confirmed by the present study, as it also shows that farms positive for Mycoplasmopsis spp. and especially M. bovis were above average in terms of herd size compared to the average in the SCALS and CWMCA.
It should be noted that Mycoplasmopsis spp. are normal colonizers of various organ systems in cattle. Therefore, the pathogen could also have entered the BTM through contamination. However, if the milking process is clean, the pathogen should not be found in the milk, as this would indicate that the pathogen is transmitted during milking and therefore represents a major health risk. As Mycoplasmopsis spp. are pathogens that spread quickly but are also self-limiting, it would be interesting in a further study to confirm whether the same farms are still positive after a few months or whether new farms have Mycoplasmopsis spp. in the bulk milk.
As M. bovis was found in only three of the 18 farms positive for Mycoplasmopsis spp., it must be noted that other species of the genus Mycoplasmopsis spp. were probably involved. In Europe, M. bovis is described as the predominant species causing mastitis, while other mycoplasmas are rare, but this may be due to a lack of testing for other species. Species such as M. bovigenitalium, M. alkalescens, M. canadense, and M. californicum have also been isolated from milk and considered possible mastitis pathogens, but it is not easy to link their presence to disease [40,46,61]. It is also noticeable that the average SCC of farms positive for Mycoplasmopsis spp. was significantly higher than the average of all farms belonging to the SCALS. At the same time, however, the average milk yield of the farm per animal per cow did not seem to be affected. This indicates subclinical problems.
When testing for S. aureus on Baird-Parker agar, presumptive S. aureus colonies were found in many BTM samples (80.1%). Nevertheless, MALDI-TOF revealed that S. aureus was present in only 18.3% of cases. Most of the remaining cases were NaS. These must also be considered as potential causative agents of SCM but may also represent contaminants in the BTM. An Italian study of 844 BTM samples found a prevalence of S. aureus of 47.2%, but only the results of the modified Baird-Parker agar are shown and no confirmation by MALDI-TOF was performed [62]. However, the fact that 18.3% of farms had S. aureus levels > 10 cfu/mL milk in the BTM still shows that the pathogen was clearly present in the sampled area and can lead to potential new S. aureus infections. The farms in which the threshold value is exceeded currently appear to have an increased risk for the spread of S. aureus. This study confirms that it is almost impossible to eliminate S. aureus from the herd. Therefore, the prevention of new infections is the most important means to limit the spread.
The prevalence of oxacillin-resistant S. aureus of 3.8% shows that resistance to ß-lactam antibiotics may be a problem in the sampled area. This prevalence is similar to prevalences from previous studies on MRSA. For example, in the Italian study of 844 BTM samples, the prevalence of MRSA was also 3.8% [23,24,37,38,62]. A study in England and Wales reported that methicillin-resistant staphylococci were present in 5% of flocks. However, the proportion of methicillin-resistant S. aureus was only 0.83%. The remaining staphylococci were resistant to NaS. Thus, the prevalence of resistant S. aureus in the United Kingdom appears to be lower than in the German region studied [63].
It will be important to monitor the development of prevalence in the future, as there is an ongoing discussion about limiting the use of antibiotics in veterinary medicine, and the use of critical important substances. An increase in oxacillin-resistant S. aureus on dairy farms may intensify this debate. Whether there is a zoonotic potential needs to be determined in future studies. Nonetheless, the risk of the transmission of MRSA to humans via milk is considered to be low [36]. However, the detection of resistant S. aureus strains in raw milk confirms the recommendation that it should not be consumed without prior pasteurization [38]. Yet, it is very important to monitor the development and presence of resistant S. aureus strains, as the increasing threat of resistance leads to problems in the treatment of animals. Moreover, a significant rise in occurrence brings about not only discussions on animal welfare problems, but also political restrictions on the use of antibiotics.
The available herd milk samples show a clear prevalence (6.3%) of Prototheca spp. in the sampled region. It seems that the pathogen is much more widespread than assumed and is therefore a possible risk factor for causing mastitis. However, unlike in Poland [25], Prototheca spp. cannot be considered the third most important mastitis pathogen in the region studied. The prevalence is comparable to the prevalence (6%) found in a Canadian study [33].
Since Prototheca spp. infections mean that several animals are usually affected at the same time and chronic processes usually develop [27,28], this has an impact on the SCC in the bulk milk of the herd. In the present study, the average SCC was also higher than the average SCC in the SCALS. The correlation between the presence of Prototheca spp. and increased SCC has also been described in previous studies [25,64]. Furthermore, it is noticeable that the number of cows on farms with Prototheca spp. in the bulk milk was significantly higher than the average. Therefore, the number of cows on the farm should be considered as an important risk factor for the presence of Prototheca spp. In contrast, an automatic milking system does not seem to be a risk factor for the presence of the pathogen. Since Prototheca spp. occur in the environment, contamination must be considered, although the contamination of BTM is only possible in the case of serious problems in husbandry and animal hygiene. In the case of a positive result, it must therefore be assumed that infected animals are present on the farm or that there is a high risk of infection so that measures must be taken in any case [5].

5. Conclusions

This study confirms the notion that testing BTM for pathogens that a herd should be completely free of, or for which a certain threshold should not be exceeded in tank milk, is most helpful in assessing the current risk to the farm. However, a negative result in the tank milk does not necessarily indicate that the farm is free of the pathogen in question. It is important to note that not all animals are milked into the bulk milk, and affected animals may shed the pathogen intermittently, so the test may be falsely negative. It is advisable to monitor the BTM several times for a safer control.
Furthermore, this study highlights the significance of monitoring the pathogens under investigation, as they represent a potential threat to the dairy industry. If these pathogens are detected in the BTM, the farm must take action to reduce the pathogen density or eliminate the pathogen. Risk factors such as herd size and the presence of an automatic milking system must be considered. An elevated SCC in the BTM may indicate that the cows being milked into the bulk tank have SCM or represent a reservoir of pathogens that could endanger other cows. It is therefore crucial to educate farmers about the pathogens described so that appropriate measures can be taken in case of an outbreak.

Author Contributions

Conceptualization, V.K. and J.K.; methodology, V.K. and J.K.; validation, J.K., formal analysis, J.K.; resources, V.K.; data curation, J.K.; writing—original draft preparation, J.K.; writing—V.K.; supervision, V.K.; project administration, V.K.; funding acquisition, V.K. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by Steinbeis Research Center Milk Science, grant number [5/22].

Institutional Review Board Statement

The animal study protocol was approved by the Institutional Review Board of Stiftung Tierärztliche Hochschule Hanover (TVO-2022-V-56, date of approval 29 August 2022).

Informed Consent Statement

Not applicable.

Data Availability Statement

The original contributions presented in the study are included in the article, further inquiries can be directed to the corresponding author.

Conflicts of Interest

The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

References

  1. Seegers, H.; Fourichon, C.; Beaudeau, F. Production Effects Related to Mastitis and Mastitis Economics in Dairy Cattle Herds. Vet. Res. 2003, 34, 475–491. [Google Scholar] [CrossRef] [PubMed]
  2. Hogeveen, H.; Huijps, K.; Lam, T. Economic Aspects of Mastitis: New Developments. N. Z. Vet. J. 2011, 59, 16–23. [Google Scholar] [CrossRef] [PubMed]
  3. Krömker, V. Kurzes Lehrbuch Milchkunde und Milchhygiene; Parey, MSV Medizinverlage: Stuttgart, Germany, 2007; pp. 47–74. [Google Scholar]
  4. Bradley, A.J. Bovine Mastitis: An Evolving Disease. Vet. J. 2002, 164, 116–128. [Google Scholar] [CrossRef] [PubMed]
  5. Krömker, V.; Schmenger, A.; Klocke, D.; Wente, N.; tho Seeth, M.; Zhang, Y.; Leimbach, S. Sinn und Unsinn der bakteriologischen Diagnostik von Tankmilchproben in der Mastitisbekämpfung. Milchpraxis 2021, 2021, 1–8. [Google Scholar]
  6. Krömker, V.; Moroni, P. Strategische Ansätze zur Bekämpfung von Mykoplasmenmastitiden. Prakt. Tierarzt 2018, 99, 1072–1079. [Google Scholar] [CrossRef]
  7. Krömker, V.; Klocke, D.; Leimbach, S.; Paduch, J.H.; Wente, N.; tho Seeth, M. Leitfaden Eutergesundheit bei Stall- und Weidehaltung. 2018. Available online: https://www.lwk-niedersachsen.de/index.cfm/portal/1/nav/2043/article/32388.html (accessed on 31 January 2024).
  8. Keefe, G. Update on Control of Staphylococcus Aureus and Streptococcus Agalactiae for Management of Mastitis. Vet. Clin. N. Am. Food Anim. Pract. 2012, 28, 203–216. [Google Scholar] [CrossRef] [PubMed]
  9. Zadoks, R.; Fitzpatrick, J. Changing Trends in Mastitis. Ir. Vet. J. 2009, 62 (Suppl. S4), S59. [Google Scholar] [CrossRef] [PubMed]
  10. Piepers, S.; De Meulemeester, L.; de Kruif, A.; Opsomer, G.; Barkema, H.W.; De Vliegher, S. Prevalence and Distribution of Mastitis Pathogens in Subclinically Infected Dairy Cows in Flanders, Belgium. J. Dairy Res. 2007, 74, 478–483. [Google Scholar] [CrossRef] [PubMed]
  11. Krömker, V. 100 Jahre Mastitisbekaempfung in Der Praktische Tierarzt. Prakt. Tierarzt 2019, 100, 969–973. [Google Scholar]
  12. Jørgensen, H.J.; Nordstoga, A.B.; Sviland, S.; Zadoks, R.N.; Sølverød, L.; Kvitle, B.; Mørk, T. Streptococcus Agalactiae in the Environment of Bovine Dairy Herds—Rewriting the Textbooks? Vet. Microbiol. 2016, 184, 64–72. [Google Scholar] [CrossRef]
  13. Katholm, J.; Bennedsgaard, T.W.; Koskinen, M.T.; Rattenborg, E. Quality of Bulk Tank Milk Samples from Danish Dairy Herds Based on Real-Time Polymerase Chain Reaction Identification of Mastitis Pathogens. J. Dairy Sci. 2012, 95, 5702–5708. [Google Scholar] [CrossRef]
  14. Mweu, M.M.; Nielsen, S.S.; Halasa, T.; Toft, N. Annual Incidence, Prevalence and Transmission Characteristics of Streptococcus Agalactiae in Danish Dairy Herds. Prev. Vet. Med. 2012, 106, 244–250. [Google Scholar] [CrossRef]
  15. German Veterinary Association (GVA). Zur Prävalenz von Mastitiserregern in Milchproben in Deutschland—Update 2019; GVA. 2022-03-14/15; Arbeitsgruppe Eutergesundheit: Gießen, Germany, 2022; Available online: https://www.dvg.net/fileadmin/Bilder/DVG/PDF/22-03-01-DVG_Fachgruppe_Mastitis2019_01032022.pdf (accessed on 25 March 2024).
  16. Bartlett, P.C.; Miller, G.Y.; Lance, S.E.; Hancock, D.D.; Heider, L.E. Managerial Risk Factors of Intramammary Infection with Streptococcus Agalactiae in Dairy Herds in Ohio. Am. J. Vet. Res. 1992, 53, 1715–1721. [Google Scholar] [CrossRef] [PubMed]
  17. Bi, Y.; Wang, Y.J.; Qin, Y.; Guix Vallverdú, R.; Maldonado García, J.; Sun, W.; Li, S.; Cao, Z. Prevalence of Bovine Mastitis Pathogens in Bulk Tank Milk in China. PLoS ONE 2016, 11, e0155621. [Google Scholar] [CrossRef]
  18. Keefe, G.P. Streptococcus agalactiae mastitis: A review. Can. Vet. J. 1997, 38, 429–437. [Google Scholar] [PubMed]
  19. Klaas, I.C.; Zadoks, R.N. An Update on Environmental Mastitis: Challenging Perceptions. Transbound. Emerg. Dis. 2017, 65, 166–185. [Google Scholar] [CrossRef]
  20. Schnitt, A.; Tenhagen, B.-A. Risk Factors for the Occurrence of Methicillin-Resistant Staphylococcus Aureus in Dairy Herds: An Update. Foodborne Pathog. Dis. 2019, 17, 2638. [Google Scholar] [CrossRef]
  21. Luini, M.; Cremonesi, P.; Magro, G.; Bianchini, V.; Minozzi, G.; Castiglioni, B.; Piccinini, R. Methicillin-Resistant Staphylococcus Aureus (MRSA) Is Associated with Low Within-Herd Prevalence of Intra-Mammary Infections in Dairy Cows: Genotyping of Isolates. Vet. Microbiol. 2015, 178, 270–274. [Google Scholar] [CrossRef]
  22. Spohr, M.; Rau, J.; Friedrich, A.; Klittich, G.; Fetsch, A.; Guerra, B.; Hammerl, J.A.; Tenhagen, B.-A. Methicillin-Resistant Staphylococcus Aureus (MRSA) in Three Dairy Herds in Southwest Germany. Zoonoses Public Health 2011, 58, 252–261. [Google Scholar] [CrossRef]
  23. Tenhagen, B.-A.; Alt, K.; Pfefferkorn, B.; Wiehle, L.; Käsbohrer, A.; Fetsch, A. Short Communication: Methicillin-Resistant Staphylococcus Aureus in Conventional and Organic Dairy Herds in Germany. J. Dairy Sci. 2018, 101, 3380–3386. [Google Scholar] [CrossRef]
  24. Kreausukon, K.; Fetsch, A.; Kraushaar, B.; Alt, K.; Müller, K.; Krömker, V.; Zessin, K.-H.; Käsbohrer, A.; Tenhagen, B.-A. Prevalence, Antimicrobial Resistance, and Molecular Characterization of Methicillin-Resistant Staphylococcus Aureus from Bulk Tank Milk of Dairy Herds. J. Dairy Sci. 2012, 95, 4382–4388. [Google Scholar] [CrossRef] [PubMed]
  25. Jagielski, T.; Roeske, K.; Bakuła, Z.; Piech, T.; Wlazło, Ł.; Bochniarz, M.; Woch, P.; Krukowski, H. A Survey on the Incidence of Prototheca Mastitis in Dairy Herds in Lublin Province, Poland. J. Dairy Sci. 2019, 102, 619–628. [Google Scholar] [CrossRef] [PubMed]
  26. Todd, J.R.; Matsumoto, T.; Ueno, R.; Murugaiyan, J.; Britten, A.; King, J.W.; Odaka, Y.; Oberle, A.; Weise, C.; Roesler, U.; et al. Medical Phycology 2017. Med. Mycol. 2018, 56 (Suppl. S1), S188–S204. [Google Scholar] [CrossRef] [PubMed]
  27. Jagielski, T.; Lagneau, P.-E. Protothecosis. A Pseudofungal Infection. J. Mycol. Médicale 2007, 17, 261–270. [Google Scholar] [CrossRef]
  28. Jánosi, S.; Ratz, F.; Szigeti, G.; Kulcsar, M.; Kerényi, J.; Laukó, T.; Katona, F.; Huszenicza, G. Pathophysiology: Review of the Microbiological, Pathological, and Clinical Aspects of Bovine Mastitis Caused by the Alga Prototheca Zopfii. Vet. Q. 2001, 23, 58–61. [Google Scholar] [CrossRef]
  29. Jagielski, T.; Bakuła, Z.; Di Mauro, S.; Casciari, C.; Cambiotti, V.; Krukowski, H.; Turchetti, B.; Ricchi, M.; Manuali, E.; Buzzini, P. A Comparative Study of the in Vitro Activity of Iodopropynyl Butylcarbamate and Amphotericin B against Prototheca Spp. Isolates from European Dairy Herds. J. Dairy Sci. 2017, 100, 7435–7445. [Google Scholar] [CrossRef] [PubMed]
  30. Jagielski, T.; Buzzini, P.; Lassa, H.; Malinowski, E.; Branda, E.; Turchetti, B.; Polleichtner, A.; Roesler, U.; Lagneau, P.-E.; Marques, S.; et al. Multicentre Etest Evaluation of in Vitro Activity of Conventional Antifungal Drugs against European Bovine Mastitis prototheca spp. Isolates. J. Antimicrob. Chemother. 2012, 67, 1945–1947. [Google Scholar] [CrossRef] [PubMed]
  31. Buzzini, P.; Turchetti, B.; Branda, E.; Goretti, M.; Amici, M.; Lagneau, P.E.; Scaccabarozzi, L.; Bronzo, V.; Moroni, P. Large-Scale Screening of the in Vitro Susceptibility of Prototheca Zopfii towards Polyene Antibiotics. Med. Mycol. 2008, 46, 511–514. [Google Scholar] [CrossRef] [PubMed]
  32. Milanov, D.; Petrović, T.; Polaček, V.; Suvajdžić, L.; Bojkovski, J. Mastitis Associated with Prototheca Zopfii—An Emerging Health and Economic Problem on Dairy Farms. J. Vet. Res. 2016, 60, 373–378. [Google Scholar] [CrossRef]
  33. Bauman, C.A.; Barkema, H.W.; Dubuc, J.; Keefe, G.P.; Kelton, D.F. Canadian National Dairy Study: Herd-Level Milk Quality. J. Dairy Sci. 2018, 101, 2679–2691. [Google Scholar] [CrossRef]
  34. Schmenger, A.; Krömker, V. Characterization, Cure Rates and Associated Risks of Clinical Mastitis in Northern Germany. Vet. Sci. 2020, 7, 170. [Google Scholar] [CrossRef] [PubMed]
  35. Neelam; Jain, V.K.; Singh, M.; Joshi, V.G.; Chhabra, R.; Singh, K.; Rana, Y.S. Virulence and Antimicrobial Resistance Gene Profiles of Staphylococcus aureus Associated with Clinical Mastitis in Cattle. PLoS ONE 2022, 17, e0264762. [Google Scholar] [CrossRef] [PubMed]
  36. Zinke, C.; Winter, M.; Möhr, E.; Krömker, V. Occurrence of Methicillin-Resistant Staphylococcus Aureus in Cheese Produced in German Farm-Dairies. Adv. Microbiol. 2012, 2, 629–633. [Google Scholar] [CrossRef]
  37. Zaatout, N.; Hezil, D. A Meta-Analysis of the Global Prevalence of Methicillin-Resistant Staphylococcus Aureus (MRSA) Isolated from Clinical and Subclinical Bovine Mastitis. J. Appl. Microbiol. 2021, 132, 140–154. [Google Scholar] [CrossRef] [PubMed]
  38. Tenhagen, B.-A.; Alt, K.; Grobbel, M.; Maurischat, S. MRSA in Bulk Tank Milk of Dairy Herds in Germany—Changes over Time. Tierärztliche Praxis. Ausg. Grosstiere Nutztiere 2023, 51, 63–69. [Google Scholar] [CrossRef] [PubMed]
  39. Gelgie, A.E.; Korsa, M.G.; Kerro Dego, O. Mycoplasma Bovis Mastitis. Curr. Res. Microb. Sci. 2022, 3, 100123. [Google Scholar] [CrossRef] [PubMed]
  40. Nicholas, R.A.J.; Fox, L.K.; Lysnyansky, I. Mycoplasma Mastitis in Cattle: To Cull or Not to Cull. Vet. J. 2016, 216, 142–147. [Google Scholar] [CrossRef]
  41. Pothmann, H.; Spergser, J.; Elmer, J.; Prunner, I.; Iwersen, M.; Klein-Jöbstl, D.; Drillich, M. Severe Mycoplasma Bovis Outbreak in an Austrian Dairy Herd. J. Vet. Diagn. Investig. 2015, 27, 777–783. [Google Scholar] [CrossRef] [PubMed]
  42. Royster, E.; Wagner, S. Treatment of Mastitis in Cattle. Vet. Clin. Food Anim. Pract. 2015, 31, 17–46. [Google Scholar] [CrossRef]
  43. Brunner, K. 2. Schweizerische Tierärztetage in Interlaken, 14–16. Mai 2014. [The 2nd Swiss Veterinarians’ Days Convention from 14–16 May in Interlaken]. Schweiz. Arch. Tierheilkd. 2014, 156, 215. [Google Scholar] [CrossRef]
  44. Francoz, D.; Bergeron, L.; Nadeau, M.; Beauchamp, G. Prevalence of Contagious Mastitis Pathogens in Bulk Tank Milk in Québec. Can. Vet. J. 2012, 53, 1071–1078. [Google Scholar]
  45. Passchyn, P.; Piepers, S.; De Meulemeester, L.; Boyen, F.; Haesebrouck, F.; De Vliegher, S. Between-herd prevalence of Mycoplasma bovis in bulk milk in Flanders, Belgium. Res. Vet. Sci. 2012, 92, 219–220. [Google Scholar] [CrossRef] [PubMed]
  46. Lysnyansky, I.; Freed, M.; Rosales, R.S.; Mikula, I.; Khateb, N.; Gerchman, I.; Van Straten, M.; Levisohn, S. An Overview of Mycoplasma Bovis Mastitis in Israel (2004–2014). Vet. J. 2016, 207, 180–183. [Google Scholar] [CrossRef] [PubMed]
  47. LKV Niedersachsen. Available online: https://lkv-ni.de/downloads/ (accessed on 31 January 2024).
  48. Riffon, R.; Sayasith, K.; Khalil, H.; Dubreuil, P.; Drolet, M.; Lagace, J. Development of a Rapid and Sensitive Test for Identification of Major Pathogens in Bovine Mastitis by PCR. J. Clin. Microbiol. 2001, 39, 2584–2589. [Google Scholar] [CrossRef]
  49. Van Kuppeveld, F.J.; van der Logt, J.T.; Angulo, A.F.; van Zoest, M.J.; Quint, W.G.; Niesters, H.G.; Galama, J.M.; Melchers, W.J. Genus- and Species-Specific Identification of Mycoplasmas by 16S RRNA Amplification. Appl. Environ. Microbiol. 1992, 58, 2606–2615. [Google Scholar] [CrossRef]
  50. Chávez González, Y.R.; Bascuñana, C.R.; Bölske, G.; Mattsson, J.G.; Fernández Molina, C.; Johansson, K.E. In Vitro Amplification of the 16S RRNA Genes from Mycoplasma Bovis and Mycoplasma Agalactiae by PCR. Vet. Microbiol. 1995, 47, 183–190. [Google Scholar] [CrossRef]
  51. German Veterinary Association (GVA). Leitlinien der Labordiagnostik der Mastitis—Probennahme und Mikrobiologische Untersuchung, 3rd ed.; Arbeitsgruppe Eutergesundheit: Gießen, Germany, 2018; Available online: https://www.dvg.net/index.php?id=1388 (accessed on 31 January 2024).
  52. Ollis, G.W.; Rawluk, S.A.; Schoonderwoerd, M.; Schipper, C. Detection of Staphylococcus Aureus in Bulk Tank Milk Using Modified Baird-Parker Culture Media. Can. Vet. J. 1995, 36, 619–623. [Google Scholar]
  53. Klocke, D.; Schmenger, A.; Krömker, V. Eutergesundheitssituation in grossen niedersächsischen Milchviehbetrieben. Prakt. Tierarzt 2020, 101, 672–683. [Google Scholar] [CrossRef]
  54. Soltau, J.B.; Einax, E.; Klengel, K.; Katholm, J.; Failing, K.; Wehrend, A.; Donat, K. Within-Herd Prevalence Thresholds for Herd-Level Detection of Mastitis Pathogens Using Multiplex Real-Time PCR in Bulk Tank Milk Samples. J. Dairy Sci. 2017, 100, 8287–8295. [Google Scholar] [CrossRef]
  55. Godkin, M.A.; Leslie, K.E. Culture of bulk tank milk as a mastitis screening test: A brief review. Can. Vet. J. 1993, 34, 601–605. [Google Scholar]
  56. Guélat-Brechbuehl, M.; Thomann, A.; Albini, S.; Moret-Stalder, S.; Reist, M.; Bodmer, M.; Michel, A.; Niederberger, M.D.; Kaufmann, T. Cross-Sectional Study of Streptococcus Species in Quarter Milk Samples of Dairy Cows in the Canton of Bern, Switzerland. Vet. Rec. 2010, 167, 211–215. [Google Scholar] [CrossRef] [PubMed]
  57. Holko, I.; Tančin, V.; Vršková, M.; Tvarožková, K. Prevalence and Antimicrobial Susceptibility of Udder Pathogens Isolated from Dairy Cows in Slovakia. J. Dairy Res. 2019, 86, 436–439. [Google Scholar] [CrossRef] [PubMed]
  58. Sztachańska, M.; Barański, W.; Janowski, T.; Pogorzelska, J.; Zduńczyk, S. Prevalence and Etiological Agents of Subclinical Mastitis at the End of Lactation in Nine Dairy Herds in North-East Poland. Pol. J. Vet. Sci. 2016, 19, 119–124. [Google Scholar] [CrossRef] [PubMed]
  59. Arcangioli, M.A.; Chazel, M.; Sellal, E.; Botrel, M.A.; Bezille, P.; Poumarat, F.; Calavas, D.; Le Grand, D. Prevalence of Mycoplasma bovis udder infection in dairy cattle: Preliminary field investigation in southeast France. N. Z. Vet. J. 2011, 59, 75–78. [Google Scholar] [CrossRef] [PubMed]
  60. Pinho, L.; Thompson, G.; Machado, M.; Carvalheira, J. Management Practices Associated with the Bulk Tank Milk Prevalence of Mycoplasma spp. in Dairy Herds in Northwestern Portugal. Prev. Vet. Med. 2013, 108, 21–27. [Google Scholar] [CrossRef] [PubMed]
  61. Fox, L.K. Mycoplasma Mastitis: Causes, Transmission, and Control. Vet. Clin. N. Am. Food Anim. Pract. 2012, 28, 225–237. [Google Scholar] [CrossRef] [PubMed]
  62. Cortimiglia, C.; Luini, M.; Bianchini, V.; Marzagalli, L.; Vezzoli, F.; Avisani, D.; Bertoletti, M.; Ianzano, A.; Franco, A.; Battisti, A. Prevalence of Staphylococcus aureus and of methicillin-resistant S. aureus clonal complexes in bulk tank milk from dairy cattle herds in Lombardy Region (Northern Italy). Epidemiol. Infect. 2016, 144, 3046–3051. [Google Scholar] [CrossRef]
  63. Fisher, E.A.; Paterson, G.K. Prevalence and Characterisation of Methicillin-Resistant Staphylococci from Bovine Bulk Tank Milk in England and Wales. J. Glob. Antimicrob. Resist. 2020, 22, 139–144. [Google Scholar] [CrossRef]
  64. Pegolo, S.; Toscano, A.; Bisutti, V.; Giannuzzi, D.; Vanzin, A.; Lisuzzo, A.; Bonsembiante, F.; Gelain, M.E.; Cecchinato, A. Streptococcus Agalactiae and Prototheca Spp. Induce Different Mammary Gland Leukocyte Responses in Holstein Cows. JDS Commun. 2022, 3, 270–274. [Google Scholar] [CrossRef]
Figure 1. Average number of cows in farms positive for each pathogen compared to average number of cows in farms of the State Control Association of Lower Saxony (SCALS) and Central Weser Milk Control Association (CWMCA).
Figure 1. Average number of cows in farms positive for each pathogen compared to average number of cows in farms of the State Control Association of Lower Saxony (SCALS) and Central Weser Milk Control Association (CWMCA).
Hygiene 04 00009 g001
Figure 2. Average milk yield per cow per day in farms positive for each pathogen compared to the average in the Central Weser Milk Control Association (CWMCA).
Figure 2. Average milk yield per cow per day in farms positive for each pathogen compared to the average in the Central Weser Milk Control Association (CWMCA).
Hygiene 04 00009 g002
Figure 3. Percentage of positive farms with an automatic milking system (AMS) compared to the percentage of farms with AMS in the State Control Associations of Lower Saxony (SCALS) and Central Weser Milk Control Association (CWMCA).
Figure 3. Percentage of positive farms with an automatic milking system (AMS) compared to the percentage of farms with AMS in the State Control Associations of Lower Saxony (SCALS) and Central Weser Milk Control Association (CWMCA).
Hygiene 04 00009 g003
Figure 4. Average somatic cell count (SCC) in the bulk tank milk in farms positive for each pathogen compared to the average SCC in farms of the State Control Association of Lower Saxony (SCALS) and Central Weser Milk Control Association (CWMCA).
Figure 4. Average somatic cell count (SCC) in the bulk tank milk in farms positive for each pathogen compared to the average SCC in farms of the State Control Association of Lower Saxony (SCALS) and Central Weser Milk Control Association (CWMCA).
Hygiene 04 00009 g004
Table 1. Nucleotide sequences of the PCR primers used for detection of Sc. agalactiae and Mycoplasmopsis spp./bovis by in vitro amplification.
Table 1. Nucleotide sequences of the PCR primers used for detection of Sc. agalactiae and Mycoplasmopsis spp./bovis by in vitro amplification.
PrimerPrimer Sequence (5′-3′)Specificity
Sag432CGT TGG TAG GAG TGG AAA ATSc. Agalactiae
Sag1018CTG CTC CGA AGA GAA AGC CTSc. Agalactiae
MGSOTGC ACC ATC TGT CAC TCT GTT AAC CTCMycoplasmopsis spp.
GPO1ACT CCT ACG GAG GCA GCA GTAMycoplasmopsis spp.
MboFCCT TTT AGA TTG GGA TAG CGG ATGM. bovis
MboRCCG TCA AGG TAG CAT TTC CTA T-M. bovis
Table 2. Primer conditions during PCR [48,49,50].
Table 2. Primer conditions during PCR [48,49,50].
Forward PrimerReverse PrimerAnnealing Temp. (°C)Size of Product Amplified
Sag432Sag101865586
GPO1MGSO60724
MboFMboR60360
Table 3. Herd prevalence for the different pathogens.
Table 3. Herd prevalence for the different pathogens.
PathogenPositive HerdsPrevalence95% Confidence Interval
Sc. agalactiae21%0.3–3.4%
Mycoplasmopsis spp.188.7%5.5–13.3%
M. bovis31.4%0.5–4.2%
S. aureus3818.3%13.6–24.1%
oxacillin-resistant S. aureus83.8%2–7.4%
Prototheca spp.136.3%3.7–10.4%
Table 4. Mean values of farms with positive pathogen detection in bulk tank milk (BTM) compared to the average of all farms belonging to the State Control Association of Lower Saxony (SCALS) and the Central Weser Milk Control Association (CWMCA).
Table 4. Mean values of farms with positive pathogen detection in bulk tank milk (BTM) compared to the average of all farms belonging to the State Control Association of Lower Saxony (SCALS) and the Central Weser Milk Control Association (CWMCA).
Number of Cows (SD/CI95)Average Milk Yield in kg per Cow per Day (SD/CI95)Farms with an Automatic Milking System in PercentAverage SCC * × 1000 (SD/CI95)
Sc. agalactiae17729.7100188
S. aureus172 (±94/137–207)31.7 (±3.8/30.3–33.1)32.1259 (±126/212–306)
Oxacillin-resistant S. aureus150 (±75/84–216)30.9 (±4.7/26.8–35)0236 (±118/132–340)
Mycoplasmopsis spp.225 (±118/161–289)33.6 (±3.8/31.5–35.7)16.7290 (±140/214–366)
M. bovis290 (±197/68–512)33 (±1.9/31.8–34.2)0207 (105/138–276)
Prototheca spp.386 (±227/237–535)32.4 (±5/29.1–35.7)11.1273 (±123/246–300)
Average of the farms in the CWMCA (2023)14432.729245
Average of the farms in the SCALS (2022/2023)123 21.9234
* SCC = somatic cell count; * SD = standard deviation; * CI95 = 95% Confidence Interval.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Kortstegge, J.; Krömker, V. Prevalence of Contagious Mastitis Pathogens in Bulk Tank Milk from Dairy Farms in Lower Saxony, Germany. Hygiene 2024, 4, 122-134. https://doi.org/10.3390/hygiene4020009

AMA Style

Kortstegge J, Krömker V. Prevalence of Contagious Mastitis Pathogens in Bulk Tank Milk from Dairy Farms in Lower Saxony, Germany. Hygiene. 2024; 4(2):122-134. https://doi.org/10.3390/hygiene4020009

Chicago/Turabian Style

Kortstegge, Jan, and Volker Krömker. 2024. "Prevalence of Contagious Mastitis Pathogens in Bulk Tank Milk from Dairy Farms in Lower Saxony, Germany" Hygiene 4, no. 2: 122-134. https://doi.org/10.3390/hygiene4020009

Article Metrics

Back to TopTop